`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner,
`
`v.
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner.
`
`
`Inter Partes Review No.: IPR2022-01226
`
`
`U.S. Patent No. 10,888,601 B2
`Filed: April 29, 2019
`Issued: January 12, 2021
`Inventor: George D. Yancopoulos
`
`Title: USE OF A VEGF ANTAGONIST TO TREAT
`ANGIOGENIC EYE DISORDERS
`
`
`PETITIONER MYLAN PHARMACEUTICALS INC.’S
`POWER OF ATTORNEY PURSUANT TO 37 C.F.R. § 42.10(b)
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.10(b), Petitioner Mylan Pharmaceuticals Inc.,
`
`hereby appoints the following practitioners as its attorneys to transact all business in
`
`the United States Patent & Trademark Office associated with its Petition for Inter
`
`Partes Review of U.S. Patent No. 10,888,601 B2:
`
`Lead
`
`Back-Up
`
`Paul J. Molino (Reg. No. 45,350)
`paul@rmmslegal.com
`
`Postal and Hand Delivery Address
`Rakoczy Molino Mazzochi Siwik LLP
`6 West Hubbard Street
`Chicago, IL 60654
`Telephone: (312) 222-6300
`Facsimile: (312) 843-6260
`
`Petitioner consents to email service at:
`MYL_REG_IPR@rmmslegal.com
`
`
`William A. Rakoczy
`(pro hac vice to be filed)
`wrakoczy@rmmslegal.com
`
`Deanne M. Mazzochi (Reg. No. 50,158)
`dmazzochi@rmmslegal.com
`
`Heinz J. Salmen
`(pro hac vice to be filed)
`hsalmen@rmmslegal.com
`
`Jeff A. Marx (Reg. No. 56,977)
`jmarx@rmmslegal.com
`
`Eric R. Hunt
`(pro hac vice to be filed)
`ehunt@rmmslegal.com
`
`Neil B. McLaughlin (Reg. No. 70,810)
`nmclaughlin@rmmslegal.com
`
`L. Scott Beall (Reg. No. 52,601)
`sbeall@rmmslegal.com
`
`Thomas H. Ehrich (Reg. No. 67,122)
`tehrich@rmmslegal.com
`
`Steven J. Birkos (Reg. No. 65,300)
`sbirkos@rmmslegal.com
`
`
`
`
`Postal and Hand Delivery Address
`Rakoczy Molino Mazzochi Siwik LLP
`6 West Hubbard Street
`Chicago, IL 60654
`Telephone: (312) 222-5127
`Facsimile: (312) 843-6260
`
`
`
`
`
`
`The individual signing below has the authority to execute this document on
`
`behalf of Mylan Pharmaceuticals Inc.
`
`
`
`
`
`
`
`
`
`Mylan Pharmaceuticals Inc.
`By: ___________________________
`
`Name: __________________________
`
`Title: ___________________________
`
`Date: ___________________________
`
`2
`
`Vinny Lee
`
`Litigation Counsel
`
`June 30, 2022
`
`
`
`CERTIFICATE OF SERVICE
`The undersigned hereby certifies that a true and correct copy of the foregoing
`
`Petitioner Mylan Pharmaceuticals Inc.’s Power of Attorney Pursuant to 37 C.F.R. §
`
`42.10(b) was served on July 1, 2022, via FedEx Priority Overnight on the Patent
`
`Owner at the correspondence address of record for U.S. Patent No. 10,888,601 B2
`
`as evidenced in Public Pair:
`
`Regeneron – Bozicevic Field & Francis LLP
`201 Redwood Shores Parkway
`Suite 200
`Redwood City, CA 94065
`
`Regeneron Pharmaceuticals, Inc.
`770 Old Saw Mill River Road
`Patent Department
`Tarrytown, NY 10591
`
`/Paul J. Molino/
`Paul J. Molino (Reg. No. 45,350)
`
`
`
`
`
`
`
`
`
`
`
`
`
`